Rationale and Design of the Double-Blind, Randomized, Placebo-Controlled Multicenter Trial on Efficacy of Early Initiation of Eplerenone Treatment in Patients with Acute Heart Failure (EARLIER)

Cite this paper

@article{Asakura2014RationaleAD, title={Rationale and Design of the Double-Blind, Randomized, Placebo-Controlled Multicenter Trial on Efficacy of Early Initiation of Eplerenone Treatment in Patients with Acute Heart Failure (EARLIER)}, author={Masanori Asakura and Haruko Yamamoto and Kuniya Asai and Akihisa Hanatani and Ken-ichi Hirata and Atsushi Hirayakma and Kazuo Kimura and Youichi Kobayashi and Shin-ichi Momomura and Yoshihisa Nakagawa and Yutaro Nishi and Yoshihiko Saito and Yasuhiro Satoh and Takahisa Yamada and Akira Yamashina and Satoshi Yasuda and Tsutomu Yoshikawa and Akiko Kada and Hiroyuki Uesaka and Masafumi Kitakaze}, journal={Cardiovascular Drugs and Therapy}, year={2014}, volume={29}, pages={179-185} }